Topiramat
Изглед
![]() | |
![]() | |
Klinički podaci | |
---|---|
Prodajno ime | Topamax, Topamax Sprinkle |
Drugs.com | Monografija |
Način primene | Oralno |
Farmakokinetički podaci | |
Poluvreme eliminacije | 19 - 23 h |
Identifikatori | |
CAS broj | 97240-79-4 ![]() |
ATC kod | N03AX11 (WHO) |
PubChem | CID 5284627 |
DrugBank | DB00273 ![]() |
ChemSpider | 4447672 ![]() |
KEGG | C07502 ![]() |
ChEMBL | CHEMBL220492 ![]() |
Hemijski podaci | |
Formula | C12H21NO8S |
Molarna masa | 339,362 |
| |
|
Topiramat je organsko jedinjenje, koje sadrži 12 atoma ugljenika i ima molekulsku masu od 339,362 Da.[1][2][3]
Osobine
[уреди | уреди извор]Osobina | Vrednost |
---|---|
Broj akceptora vodonika | 8 |
Broj donora vodonika | 1 |
Broj rotacionih veza | 3 |
Particioni koeficijent[4] (ALogP) | -1,9 |
Rastvorljivost[5] (logS, log(mol/L)) | -0,9 |
Polarna površina[6] (PSA, Å2) | 123,9 |
Reference
[уреди | уреди извор]- ^ Blum D, Meador K, Biton V, Fakhoury T, Shneker B, Chung S, Mills K, Hammer A, Isojarvi J: Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Blum, D.; Meador, K.; Biton, V.; Fakhoury, T.; Shneker, B.; Chung, S.; Mills, K.; Hammer, A.; Isojärvi, J. (2006 Aug 8). „Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy”. Neurology. 67 (3): 400—6. PMID 16894098. doi:10.1212/01.wnl.0000232737.72555.06. Проверите вредност парамет(а)ра за датум:
|date=
(помоћ). . - ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889
. PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
- ^ Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
[уреди | уреди извор]![]() | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |